SEP
TMDX icon

Signature Equity Partners’s Transmedics TMDX Stock Holding History

Signature Equity Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,195
Closed -$119K – 1701
2026
Q1 		$119K Buy
+1,195
New +$156K 0.06% 259

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Asset Management International
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hood River Capital Management
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Signature Equity Partners's TMDX Position: Q2 2026 in Review

Signature Equity Partners sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 1,195 shares — an estimated $119K sold.

Signature Equity Partners first reported a position in TMDX in Q1 2026 and held it in 1 quarter. The position peaked at $119K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Signature Equity Partners reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Signature Equity Partners sold 1,195 Transmedics shares in Q2 2026, an estimated $119K.
  • Signature Equity Partners first reported a position in Transmedics in Q1 2026 and held it in 1 quarter.
  • Signature Equity Partners's Transmedics position peaked at $119K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.